RXRX - Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.

52W High

$12.36

52W Low

$3.79

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.91

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-5.31

EV/Revenue (<3 favorable)

24.42

P/S (TTM) (<3 favorable)

31.16

P/B (<3 favorable)

2.19

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

4.74%

Institutions (25–75% balanced)

69.30%

Shares Outstanding

429,710,000

Float

416,216,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

64,596,000

Gross Profit (TTM)

-433,468,992

EPS (TTM)

-1.81

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-9.17%

ROE (TTM) (>15% strong)

-0.86%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.33

Momentum

Bearish momentum

Value

-0.2123

-0.2418

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025